AGP Picks
View all

Genexa takes over NYC with nighttime ads about kids' medicine labels

Nov. 17, 2026
Genexa takes over NYC with nighttime ads about kids' medicine labels
By AI, Created 13:01 UTC, Nov 17, 2026, AGP -

Genexa and Super Nice launched a New York City campaign timed for cold and flu season to push parents to scrutinize children’s medicine labels. The work uses provocative out-of-home ads to spotlight ingredients that can also show up in cosmetics, cleaning products and pesticides, as the brand tries to grow its clean OTC medicine business.

Why it matters: - Genexa is betting parents will pay more attention to what is in kids’ cold and flu medicine when the message is delivered in the middle of the night. - The campaign ties a broader clean-label movement to over-the-counter medicine, a category Genexa believes is overdue for the same scrutiny consumers have brought to food and beauty. - The push comes as parents weigh efficacy, safety and simplicity when a child is sick at 2 a.m.

What happened: - Genexa launched a New York City out-of-home campaign with independent creative agency Super Nice. - The ads run under the Feel Better campaign and use unbranded visuals for cosmetics, cleaning supplies and pesticides. - The creative reveals a link: ingredients found in those products can also appear in children’s cold and flu medicines. - At night, the work uses glow-in-the-dark red messaging that reads, “2 A.M. IS NO TIME TO DISCOVER WHAT’S IN YOUR KID’S MEDICINE.” - The wild postings will be on view through Thanksgiving weekend. - New Yorkers can also see Sparkie roaming the city.

The details: - Genexa makes OTC medicine with the same active ingredients as leading brands, but without artificial additives. - The company says its medicines use 0% artificial additives. - Genexa says 80% of parents’ sleep suffers when their kids’ sleep does, citing the National Sleep Foundation. - Genexa cites NielsenIQ data showing 82% of consumers globally want more transparent health and wellness labels. - The brand cites an FRC 2025 ingredient review in which pediatricians overwhelmingly preferred Genexa’s ingredient profiles over comparable leading brands. - The review covered Kids Pain Reliever & Fever Reducer liquid acetaminophen, Infants Pain Reliever & Fever Reducer liquid acetaminophen, Kids Daytime Cough & Chest Congestion, Kids Long-Acting Nighttime Cough Relief and Kids Allergy Relief. - Super Nice led strategy, production, content and FeelBetterMedicine.org. - The campaign also points shoppers to Genexa.com and the brand’s social channels. - Genexa is available at Target, Walmart, Whole Foods, Sprouts, CVS, Walgreens and Amazon.

Between the lines: - The campaign borrows tactics from fashion and beauty marketing, where clean-label language has become a selling point. - Genexa is positioning pediatric medicine as the next category where ingredient transparency can drive choice, not just clinical performance. - The dark, disruptive creative is designed to meet anxious parents in the exact moment they are looking for relief. - Genexa is also trying to turn trust into a broader brand moat, pairing retail expansion with creator and pediatrician relationships.

What's next: - Genexa says it is building relationships with families, creators and pediatricians as it pushes the clean-medicine message. - The company has launched in Target’s Baby aisle and says it captured 14% of the store’s infant pain category in four weeks, up 366% year over year. - Genexa says it has added more than 400 creators to its affiliate network. - The company also launched Clean Medicine Club, a network of pediatric practices in Atlanta and New York reaching 15,000 families. - Genexa says pediatric OTC sales are up 43% year over year over the past 12 weeks. - Investors include Donald Glover, Katherine Schwarzenegger Pratt and Sophia Bush.

The bottom line: - Genexa is trying to make ingredient transparency a must-have in kids’ medicine, not just a nice-to-have in food and beauty.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Global Advertising News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Global Advertising News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.